tweetindex
TR

SARS‑CoV‑2 (COVID-19) ✓

@COVID19_disease · joined 17 Oct 2021

Coronavirus and other health-related updates. Regular updates on Outbreaks, Pathogens For more updates follow @COVID19_disease

60 897Followers
890Following
7 125Posts total
4.2MViews on collected posts

Son gönderiler

@COVID19_disease I predict that this sort of technology will prove that anti-vaxers are just fucking scared of needles. They made up all this fake science and mumbo-jumbo just to avoid the needle lol 2.2K views · 59 likes · 2 reposts · 2 replies Open on X →
https://t.co/evts2em2b9 4.2K views · 174 likes · 32 reposts · 2 replies Open on X →
This is a very major breakthrough. Please do follow us for evidence-based scientific explanations and insights. 4.1K views · 183 likes · 8 reposts · 3 replies Open on X →
This is huge because: · Needle-free = easier rollout, less waste, less fear. · Lung-delivered = stops viruses at the gate, not after they've breached. · Could be rapidly adapted for flu, RSV, even future pandemics. 3.8K views · 229 likes · 18 reposts · 1 replies Open on X →
The results? Both were safe at all doses. But ChAd blew HuAd out of the water on immunogenicity. The optimal dose of ChAd triggered tripartite immunity: 1. T cells 2. Trained innate immunity 3. Antibodies All in the lungs. 4.2K views · 177 likes · 16 reposts · 1 replies Open on X →
They ran a Phase 1 trial (NCT05094609) on healthy adults who already had 3 mRNA shots. Some had prior COVID, some didn't. They tested two viral vectors: human adenovirus (HuAd) and chimpanzee adenovirus (ChAd). 4.6K views · 153 likes · 11 reposts · 1 replies Open on X →
Enter Drs. Fiona Smaill & Zhou Xing. They built a nebulizer that turns a vaccine into an aerosol mist. You inhale it for 2 minutes. It goes straight to the lungs the front door of infection. No needles. No waiting in line for a shot. 5.5K views · 200 likes · 17 reposts · 2 replies Open on X →
First, the problem: Current COVID shots are great, but they work mostly in the blood. Viruses like SARS-CoV-2 enter through your nose and lungs where vaccine-induced antibodies often don't reach well enough. That's a blind spot. Especially for variants. 6.4K views · 216 likes · 15 reposts · 1 replies Open on X →
🚨 BREAKTHROUGH: Scientists from McMaster University have developed AeroVax a breathable vaccine mist that delivers immunity directly to the lungs in just 2 minutes.🧵 78.3K views · 2.1K likes · 400 reposts · 25 replies Open on X →
@COVID19_disease So will this happen maybe, eventually or after people who need it now pass away? I see so many or these "promising advances" that never actually happen 981 views · 12 likes · 0 reposts · 2 replies Open on X →
https://t.co/Szeohe9i1N 3.1K views · 56 likes · 8 reposts · 1 replies Open on X →
🚨 BREAKTHROUGH: Scientists have engineered a virus that invades and destroys glioblastoma one of the deadliest brain cancers while turning the immune system into a relentless tumor-killing force This could be a historic shift in cancer treatment https://t.co/Tl4v2303Bk 48.1K views · 2.7K likes · 570 reposts · 49 replies Open on X →
🚨 BREAKTHROUGH: MD Anderson Researchers dropped a cancer bomb mRNA COVID vaccines + immunotherapy = 2x survival at 3 years.🧵 21.3K views · 444 likes · 92 reposts · 6 replies Open on X →
🚨 BREAKING: A livestock bacterium is silently spreading across Europe and it's now transmitting human-to-human.🧵 https://t.co/2BjIlih3ih 60K views · 968 likes · 312 reposts · 13 replies Open on X →
@COVID19_disease https://t.co/AuCiVu32xB 18.4K views · 1K likes · 6 reposts · 7 replies Open on X →
🚨 BREAKTHROUGH: Scientists have created a sugar-coated nanoparticle that blocks COVID-19 from infecting cells with 99% effectiveness in lab tests. This isn't a vaccine. It's a decoy. And it could change how we fight viruses forever. Here’s how it works.🧵 90.7K views · 2.7K likes · 640 reposts · 40 replies Open on X →
@COVID19_disease She can break my heart and fix it again 😭 8.6K views · 228 likes · 6 reposts · 9 replies Open on X →
https://t.co/hsJMbsDj8S 17.8K views · 86 likes · 16 reposts · 2 replies Open on X →
🚨 BREAKTHROUGH: 25-year-old Argentinian biologist Pilar Ferrer has developed an injectable gel that helps repair damaged heart tissue after a heart attack https://t.co/RSlZOtICAh 607.8K views · 24.9K likes · 3.3K reposts · 198 replies Open on X →
🚨 BREAKTHROUGH: A molecule in broccoli & cabbage just killed 90% of cavity-causing bacteria in lab studies. And no, it’s not fluoride. Here’s how this changes everything about dental care.🧵 https://t.co/WrEAO0bPTx 262.4K views · 3.6K likes · 477 reposts · 21 replies Open on X →
https://t.co/1cWqxQGW76 161.4K views · 100 likes · 29 reposts · 21 replies Open on X →
🚨 BREAKING: COVID IS SURGING ACROSS THE U.S. 🇺🇸 Cases are rising or likely rising in 47 states with no state currently estimated to be seeing a decline. Schools are already canceling classes as infections spread. https://t.co/FxkcTnzD8g 2.8M views · 8K likes · 2.4K reposts · 1.7K replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 22 gönderi, 10K–100K takipçi aralığıyla yan yana. kendi kitlesinin çok ötesine gösteriliyor ve kitle tepki veriyor.

Medyan görüntülenme13 171bu hesap92410K–100K için medyan
Erişim, %21.63%bu hesap3.62%10K–100K için medyan
Etkileşim, %3.40%bu hesap1.52%10K–100K için medyan
ÖlçütBu hesap10K–100K için medyanOran
Gönderi başına medyan görüntülenme13 17192414.2×
Erişim (görüntülenme ÷ takipçi)21.63%3.62%5.97×
Etkileşim oranı3.40%1.52%2.23×

Bu aralıktaki diğer hesaplar →   Başka bir hesapla karşılaştır →   Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

60K1 Sep
21.3K2 Sep
48.1K3 Sep
3.1K
981
78.3K6 Sep
6.4K
5.5K
4.6K
4.2K
3.8K
4.1K
4.2K
2.2K

Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

2.19%1 Sep
2.57%2 Sep
6.95%3 Sep
2.13%
1.43%
3.20%6 Sep
3.65%
4.02%
3.59%
4.67%
6.44%
4.71%
5.01%
2.92%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes69.7%48 237 in total
Reposts12.1%8 361 in total
Replies3.1%2 135 in total
Quotes1.9%1 312 in total
Bookmarks13.2%9 165 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Benzer hesaplar